Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study.
Martin BlahoJitka MacháčkováPetr DítěPavol HoléczyPetr ŠedivýRobert PsárZdeněk ŠvageraDominik VilímekDaniel TomanOndřej UrbanMarek BuzgaPublished in: Obesity surgery (2022)
Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI < 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.
Keyphrases
- magnetic resonance imaging
- weight loss
- insulin resistance
- mass spectrometry
- adipose tissue
- weight gain
- end stage renal disease
- body mass index
- multiple sclerosis
- contrast enhanced
- ejection fraction
- metabolic syndrome
- newly diagnosed
- type diabetes
- physical activity
- bariatric surgery
- high fat diet
- fatty acid
- prognostic factors
- computed tomography
- peritoneal dialysis
- skeletal muscle
- patient reported